Clinical observation of Qanliexian decoction in the treatment of NIH III A prostatitis

OBJECTIVE To study the efficacy of Qianliexian Decoction in the treatment of National Institute of Health (NIH) III A prostatitis. METHODS Forty-six patients with NIH III A prostatitis were treated by oral Qianliexian Decoction 1 dose and twice a day for 30 days. The results of the treatment were evaluated according to the NIH chronic prostatitis symptom index (NIH-CPSI) and leukocyte counts in the expressed prostatic secretions (EPS). RESULTS The overall scores before and after the treatment were (32.3 +/- 7.4) and (17.8 +/- 4.2) on NIH-CPSI (P < 0.01), (13.2 +/- 3.6) and (7.8 +/- 2.3) on pain or discomfort (P < 0.01), (4.5 +/- 1.2) and (1.4 +/- 0.8) on urinary symptoms (P < 0.01), (14.6 +/- 7.4) and (8.6 +/- 3.5) on the quality of life (P < 0.01), and (20.6 +/- 2.4) /HP and (5.6 +/- 3.2)/HP on leukocyte counts, respectively. The decoction cured 8 of the patients and was shown to be obviously effective in 11 cases, effective in 20 and ineffective in 7, with a total efficacy rate of 84.78%. CONCLUSION Qianliexian Decoction is quite effective for the treatment of NIH III A prostatitis.